NTRA Natera, Inc.

NASDAQ
$287.47

Natera, Inc. (NTRA) is expected to report earnings on February 4, 2027, after the market close. The consensus earnings estimate is a loss of $0.04 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -10.2% since its last earnings release on November 5, 2026.

Natera Missed Consensus Estimates, Raises Guidance
Thursday, November 5, 2026 · 4:05 PM ET
Earnings Date
4th Quarter, Dec 2026
Feb 4
Thursday · 4:05 PM ET
Earnings Whisper
-
vs ($0.04)
Rev est $758.8M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $312.16

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Natera, Inc.

Natera is a pioneer and global leader in cell-free DNA testing from a simple blood draw.

Sector

Healthcare

Industry

Medical Labs & Research

Charts powered in part by Lightweight Charts™ by TradingView.